Please see Important Saftey Information at the bottom of this page
Information for Healthcare Professionals

Ordering FluMist®

To pre-book or order FluMist for the 2009-2010 season, please contact the vaccine distributors listed below:

ASD Healthcare
1-866-281-4FLU (4358)

Besse Medical/Amerisource Bergen Specialty Group
1-800-543-2111

McKesson
Contact your McKesson account manager for ordering FluMist, or contact our Moore Medical division below.

Moore Medical LLC
1-800-234-1464

Storing FluMist

STORE REFRIGERATED — DO NOT FREEZE

FluMist is supplied for intranasal delivery in packages of 10 pre-filled, single-use sprayers.

FluMist should be stored in a refrigerator between 2 — 8 °C (35 — 46 °F) upon receipt and until use before the expiration date. Do not freeze.

The cold chain (2 — 8 °C) must be maintained when transporting FluMist.

Next: Vaccines for Children Program

External Pack

Important Safety Information

FluMist® is a vaccine indicated for active immunization of individuals 2 - 49 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

FluMist is contraindicated in individuals with history of hypersensitivity to eggs, egg proteins, gentamicin, gelatin or arginine or with life-threatening reactions to previous influenza vaccinations, and in children and adolescents receiving concomitant aspirin or aspirin-containing therapy.

Do not administer FluMist to children <24 months of age due to an increased risk of hospitalization and wheezing that was observed in clinical trials. FluMist should not be administered to any individual with asthma and to children <5 years of age with recurrent wheezing unless the potential benefit outweighs the potential risk. Do not administer FluMist to individuals with severe asthma or active wheezing.

If Guillain-Barré syndrome has occurred with prior influenza vaccination or if an individual is immunocompromised, the decision to give FluMist should be based on careful consideration of the potential benefits and risks. FluMist should not be administered to individuals with underlying medical conditions predisposing them to wild-type influenza infection complications unless the potential benefit outweighs the potential risk. FluMist should be given to a pregnant woman only if clearly needed.

Most common adverse reactions (occurring at ≥10% in individuals receiving FluMist and at least 5% greater than in placebo) are runny nose or nasal congestion in recipients of all ages, fever >100°F in children 2-6 years of age, and sore throat in adults.

FluMist may not protect all individuals receiving the vaccine. FluMist is for intranasal administration only.